![]() ![]() Overview page represent trading in all U.S. Indexes: Index quotes may be real-time or delayed as per exchange requirements refer to time stamps for information on any delays. Copyright © FactSet Research Systems Inc. Fundamental company data and analyst estimates provided by FactSet. International stock quotes are delayed as per exchange requirements. ![]() stock quotes reflect trades reported through Nasdaq only comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.Stocks: Real-time U.S. On the date of publication, Larry Ramer held a long position in EXAS. The latter channels tend to advertise a great deal on Roku. ease going forward, I expect more sectors’ ad spending to climb.įinally, I expect Roku to benefit significantly both from more companies’ realization that streaming is rapidly gaining market share and continued tough competition among paid streaming channels. However, the company reported that the ad spending of some sectors, including “consumer packaging and health and wellness,” rebounded in Q2. advertising market flat (year-over-year) in Q2. In its Q2 Shareholder Letter, Roku noted that “While Q2 Platform revenue exceeded our expectations, the macro environment continued to create uncertainty with the total U.S. Also noteworthy is that the company’s streaming hours increased by 4.4 billion hours year-over-year to 25.1 billion hours. ![]() Last quarter, the company’s top line jumped 11% versus the same period a year earlier to $847 million, while its gross profit climbed 7% year-over-year to $378 million. (That’s not surprising since Roku is by far the most popular operating system for streaming TVs at this point). Roku ( ROKU)Īs the popularity of streaming continues to grow rapidly, Roku’s (NASDAQ: ROKU ) top line keeps increasing quite quickly. As a result, I’m very bullish on the test’s outlook. Moreover, as I noted in a previous column, “Baylor Scott & White, a primary care organization (and hospital owner) in Texas, “ will administer approximately 50,000 Multi-Cancer Early Detection tests (from EXAS) to (its) patients.”īaylor is a huge healthcare organization, so its willingness to utilize Exact Sciences’ test bodes well for the test’s adoption by other such entities. Indeed, one of my family members recently had to wait three months before receiving a colonoscopy that she requested. Exact Sciences (EXAS)Īfter Exact Sciences (NASDAQ: EXAS) reported very favorable data on its new colon cancer screening product, investment bank Canaccord Genuity predicted that EXAS could eventually obtain at least a 50% share of all colon cancer screenings.Įxact Sciences has said that there is currently a “backlog” of people waiting for colonoscopies, and the company’s colon cancer screening product could help improve that situation. What’s more, on the leisure side of the equation, I expect the travel boom to ease next year, and I think there’s a good chance that many more tech-savvy consumers will, as a result, use Zoom to connect with their friends and family who live far away from them. Meanwhile, the company is intensively working to expand its business in Asia, and that initiative could bear fruit by next year. executives… expect the number of hybrid and remote workers to increase” by 2.2% and 1%, respectively, between 20. I think that this forecast is overly conservative and likely reflects the prevailing view that the work-from-home trend is likely poised to dissipate and will at least stagnate.īut that theory appears to be misplaced, as a recent study found that “most U.S. The mean forecast, however, calls for Zoom’s EPS to decline next year to $4.54. Yet analysts, on average, expect the company’s earnings per share to jump a healthy 6.8% this year to $4.67. That’s well below the average price-earnings ratio of the S&P 500, which currently stands at 25.8x. Specifically, the shares are changing hands at a forward price-to-earnings ratio of just 16.6x. After being dramatically overvalued during the pandemic, Zoom Video (NASDAQ: ZM ) now appears to be significantly undervalued. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |